303 related articles for article (PubMed ID: 29129451)
1. Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.
Russell LB; Kim SY; Cosgriff B; Pentakota SR; Schrag SJ; Sobanjo-Ter Meulen A; Verani JR; Sinha A
Vaccine; 2017 Dec; 35(49 Pt B):6905-6914. PubMed ID: 29129451
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
[TBL] [Abstract][Full Text] [Related]
4. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?
Oster G; Edelsberg J; Hennegan K; Lewin C; Narasimhan V; Slobod K; Edwards MS; Baker CJ
Vaccine; 2014 Aug; 32(37):4778-85. PubMed ID: 24992717
[TBL] [Abstract][Full Text] [Related]
5. Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness.
Procter SR; Gonçalves BP; Paul P; Chandna J; Seedat F; Koukounari A; Hutubessy R; Trotter C; Lawn JE; Jit M
PLoS Med; 2023 Mar; 20(3):e1004068. PubMed ID: 36917564
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of maternal immunization against neonatal invasive Group B Streptococcus in the Netherlands.
Hahn BA; de Gier B; van Kassel MN; Bijlsma MW; van Leeuwen E; Wouters MGAJ; van der Ende A; van de Beek D; Wallinga J; Hahné SJM; Jan van Hoek A
Vaccine; 2021 May; 39(21):2876-2885. PubMed ID: 33895018
[TBL] [Abstract][Full Text] [Related]
8. Prospects for preventing infant invasive GBS disease through maternal vaccination.
Madhi SA; Dangor Z
Vaccine; 2017 Aug; 35(35 Pt A):4457-4460. PubMed ID: 28237500
[TBL] [Abstract][Full Text] [Related]
9. Antenatal syphilis screening using point-of-care testing in Sub-Saharan African countries: a cost-effectiveness analysis.
Kuznik A; Lamorde M; Nyabigambo A; Manabe YC
PLoS Med; 2013 Nov; 10(11):e1001545. PubMed ID: 24223524
[TBL] [Abstract][Full Text] [Related]
10. Group B Streptococcus: Trials and Tribulations.
Davies HG; Carreras-Abad C; Le Doare K; Heath PT
Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S72-S76. PubMed ID: 31205250
[TBL] [Abstract][Full Text] [Related]
11. The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus.
Berardi A; Cassetti T; Creti R; Vocale C; Ambretti S; Sarti M; Facchinetti F; Cose S; ; Heath P; Le Doare K
Ital J Pediatr; 2020 Oct; 46(1):160. PubMed ID: 33115542
[TBL] [Abstract][Full Text] [Related]
12. Potential cost-effectiveness of a maternal Group B streptococcal vaccine in The Gambia.
Ahmed N; Giorgakoudi K; Usuf E; Okomo U; Clarke E; Kampmann B; Le Doare K; Trotter C
Vaccine; 2020 Mar; 38(15):3096-3104. PubMed ID: 32147298
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
14. Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.
Seale AC; Bianchi-Jassir F; Russell NJ; Kohli-Lynch M; Tann CJ; Hall J; Madrid L; Blencowe H; Cousens S; Baker CJ; Bartlett L; Cutland C; Gravett MG; Heath PT; Ip M; Le Doare K; Madhi SA; Rubens CE; Saha SK; Schrag SJ; Sobanjo-Ter Meulen A; Vekemans J; Lawn JE
Clin Infect Dis; 2017 Nov; 65(suppl_2):S200-S219. PubMed ID: 29117332
[TBL] [Abstract][Full Text] [Related]
15. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
[TBL] [Abstract][Full Text] [Related]
16. Early-onset group B streptococcal disease in African countries and maternal vaccination strategies.
Dangor Z; Seale AC; Baba V; Kwatra G
Front Public Health; 2023; 11():1214844. PubMed ID: 37457277
[TBL] [Abstract][Full Text] [Related]
17. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
[TBL] [Abstract][Full Text] [Related]
18. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
Kobayashi M; Schrag SJ; Alderson MR; Madhi SA; Baker CJ; Sobanjo-Ter Meulen A; Kaslow DC; Smith PG; Moorthy VS; Vekemans J
Vaccine; 2019 Nov; 37(50):7307-7314. PubMed ID: 28017431
[TBL] [Abstract][Full Text] [Related]
19. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
20. Disease Burden of Group B Streptococcus Among Infants in Sub-Saharan Africa: A Systematic Literature Review and Meta-analysis.
Sinha A; Russell LB; Tomczyk S; Verani JR; Schrag SJ; Berkley JA; Mohammed M; Sigauque B; Kim SY;
Pediatr Infect Dis J; 2016 Sep; 35(9):933-42. PubMed ID: 27213263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
